Episode 226: Superwarfarin Toxicity

Superwarfarin toxicity: recognition, reversal, and prolonged vitamin K therapy.

Hosts:

Mac Josh Reandelar, DO

Avir Mitra, MD

https://media.blubrry.com/coreem/content.blubrry.com/coreem/Superwarfarin_Toxicity.mp3

Download

Leave a Comment

Tags: Toxicology

Show Notes

Toxicology & Pathophysiology

Long-acting vitamin K antagonists (LA-VKAs), developed as potent rodenticides

Examples: brodifacoum, bromadiolone, difenacoum, chlorophacinone

Much more potent + far longer acting than warfarin

MOA: inhibits VKORC1 → ↓ vitamin K recycling → impaired γ-carboxylation

↓ factors II, VII, IX, X + proteins C/S

Highly lipophilic → extensive tissue/fat sequestration + slow redistribution

Effect can persist weeks-months; occasionally much longer

Not dialyzable

Exposure: large acute ingestion OR repeated low-dose exposure

Source may be unclear, concealed, or initially unknown

Presentation

Often delayed + insidious

Severe coagulopathy may precede obvious bleeding

Early: epistaxis, gingival bleeding, bruising/ecchymoses, hematuria

Classic clue: well-appearing pt + extraordinarily abnormal coagulation studies

Severe bleeding: RP hemorrhage, ICH, spinal hemorrhage, tamponade, major GI/GU bleeding

RP bleed → flank/back pain ± CVA tenderness

Labs & Diagnosis

PT/INR: profoundly elevated, sometimes beyond assay range

aPTT: may also be markedly prolonged with severe factor depletion

CBC/plts: often initially preserved unless major blood loss/other process

LFTs: often relatively normal

Profound INR + no warfarin + preserved liver function → think superwarfarin

CT based on bleeding site; CT A/P for suspected RP hemorrhage

Confirm: specialized serum/blood testing for long-acting anticoagulants, typically chromatography/mass spec

Do NOT delay resuscitation/treatment for confirmatory testing

Elevated INR: Differential

Superwarfarin exposure

Warfarin toxicity

Severe vitamin K deficiency: malnutrition, malabsorption, prolonged abx

Liver failure/cirrhosis

DIC

Acquired factor deficiency/inhibitor

Helpful discriminators

Liver dz → abnormal hepatic profile/clinical context

DIC → ↓ plts, ↓ fibrinogen, ↑ D-dimer

No warfarin + massive INR + relatively normal LFTs/plts → superwarfarin rises on the differential

ED Management

Major/Life-Threatening Bleeding

Goal: replace factors NOW + restore endogenous synthesis

4F-PCC = preferred factor replacement

Fast, predictable correction

Small volume

No thawing/type matching

FFP if PCC unavailable

Slower + large volume/TACO risk

Give IV vitamin K concurrently

PCC = immediate bridge; vitamin K = sustained factor synthesis

Recheck INR + clinical bleeding response

Repeat PCC generally not routine; reassess before redosing

No Major Bleeding, Critical INR

Vitamin K is primary therapy

High-dose PO vitamin K often preferred when clinically stable

Avoid unnecessary PCC/FFP if no major bleeding

Serial INR monitoring essential

Poison Control

Call early

Helps with:

Confirmatory testing

Vitamin K dosing

Duration of therapy

Monitoring/taper strategy

Outpatient planning

The Long Game

This is NOT standard warfarin toxicity

Vitamin K requirements may persist for months

Discharge only when bleeding controlled + clinically stable on oral regimen

Close serial INR follow-up mandatory

Slowly taper vitamin K under laboratory guidance

Stopping too early → rebound INR elevation + recurrent bleeding

Take Home Points

Massive unexplained INR + relatively normal liver function → think superwarfarin

Major bleeding → 4F-PCC + IV vitamin K

Expect prolonged vitamin K therapy + meticulous INR follow-up

Read More